Updated: January 29, 2026
Alternatives to Methotrexate If You Can't Fill Your Prescription
Author
Peter Daggett

Summarize with AI
- Important: Always Consult Your Doctor Before Switching
- Alternatives for Rheumatoid Arthritis (RA) and Psoriatic Arthritis
- 1. Leflunomide (Arava)
- 2. Hydroxychloroquine (Plaquenil)
- 3. Sulfasalazine
- 4. Biologic DMARDs (TNF inhibitors and others)
- Alternatives for Psoriasis
- Alternatives for Cancer Patients
- What to Tell Your Doctor
Can't get methotrexate due to the shortage? Learn about proven alternatives for rheumatoid arthritis, psoriasis, and cancer — and how to talk to your doctor about switching.
Methotrexate has been in shortage since March 2023, and for many patients, waiting isn't an option. Whether you're managing rheumatoid arthritis, psoriasis, or a cancer diagnosis, your treatment shouldn't be delayed. Here is a guide to the most established alternatives — broken down by condition — and how to approach the conversation with your provider.
Important: Always Consult Your Doctor Before Switching
Methotrexate has a specific place in your treatment plan, and switching medications — even to something in the same class — requires your provider's oversight. Some alternatives take weeks to become effective, some require different monitoring labs, and some are not appropriate for certain patients based on their medical history.
Alternatives for Rheumatoid Arthritis (RA) and Psoriatic Arthritis
Methotrexate is the first-line DMARD for RA. If it's unavailable, these alternatives have strong clinical evidence:
1. Leflunomide (Arava)
Leflunomide is the closest head-to-head competitor to methotrexate for RA. Like methotrexate, it is a DMARD that slows joint damage and reduces inflammation. It works differently — by inhibiting pyrimidine synthesis — but achieves comparable clinical outcomes in many patients.
Typical dose: 10–20 mg once daily (oral)
Key consideration: Also contraindicated in pregnancy and requires liver monitoring; long half-life means drug stays in system for months even after stopping
Cost: Generic leflunomide is affordable, typically $15–$50/month with a coupon
2. Hydroxychloroquine (Plaquenil)
Hydroxychloroquine is a milder DMARD frequently used for lupus and early or mild RA. It is not as powerful as methotrexate but has an excellent long-term safety profile. It's often used in combination with other DMARDs.
Key consideration: Requires annual eye exams (rare risk of retinal toxicity at high cumulative doses); safe in pregnancy
3. Sulfasalazine
Sulfasalazine is another first-line DMARD option for RA and psoriatic arthritis. It is also one of the few DMARDs considered safe in pregnancy, making it a key alternative for patients who are pregnant or planning to conceive.
4. Biologic DMARDs (TNF inhibitors and others)
If your disease is moderate to severe or has not responded to conventional DMARDs, biologic therapies are highly effective. Common options include:
Adalimumab (Humira, biosimilars): TNF inhibitor; wide biosimilar availability has reduced costs significantly
Etanercept (Enbrel): TNF inhibitor; subcutaneous injection weekly or twice weekly
Abatacept (Orencia), tocilizumab (Actemra): For patients who cannot tolerate TNF inhibitors
Note: Biologics require prior authorization from insurance and are significantly more expensive than methotrexate without assistance programs. They also come with their own monitoring requirements.
Alternatives for Psoriasis
For plaque psoriasis, methotrexate is a systemic treatment option. If unavailable, alternatives include:
Apremilast (Otezla): Oral PDE4 inhibitor; no lab monitoring required, but less potent for severe disease
IL-17 inhibitors (secukinumab/Cosentyx, ixekizumab/Taltz): Highly effective biologics for moderate-to-severe psoriasis
Acitretin: Oral retinoid; option for certain psoriasis types, but contraindicated in women of childbearing potential
Alternatives for Cancer Patients
For cancer patients, there is no universal substitute for methotrexate. The appropriate alternative depends on cancer type, stage, and treatment regimen. Your oncologist will lead this decision. In some cases, treatment regimens can be modified or other chemotherapy agents substituted. For leukemia patients requiring intrathecal administration, your institution's oncology team will follow ASHP guidelines for shortage management.
What to Tell Your Doctor
When calling your provider's office to discuss switching medications, have this ready:
Your current dose and how long you've been on methotrexate
Which pharmacies you've already checked (showing you've done the legwork)
Your insurance formulary (your pharmacist or insurer can give you this)
Whether cost or monitoring burden is a concern for you with potential alternatives
Before giving up on finding methotrexate, it may still be worth searching. Check out our guide on how to find methotrexate near you or let medfinder do the searching for you.
Frequently Asked Questions
Leflunomide (Arava) is widely considered the closest alternative to methotrexate for RA, with comparable clinical trial data. Hydroxychloroquine and sulfasalazine are milder options, while biologic DMARDs like adalimumab (Humira) are used for moderate-to-severe disease that doesn't respond to conventional DMARDs.
Do not abruptly stop methotrexate without contacting your prescriber first, especially for cancer treatment. For autoimmune conditions, sudden discontinuation can cause disease flares. Your doctor may prescribe a bridge medication or help you find an alternative source while maintaining continuity of care.
For rheumatoid arthritis, leflunomide (Arava) is an effective substitute. Clinical trials show comparable efficacy to methotrexate in reducing joint pain, swelling, and radiographic progression. However, leflunomide has a much longer half-life and similarly cannot be used in pregnancy. Your rheumatologist should guide this switch.
Yes. Sulfasalazine and hydroxychloroquine are considered relatively safe in pregnancy and are commonly used for RA and inflammatory arthritis in pregnant patients. Both methotrexate and leflunomide are absolutely contraindicated in pregnancy. Always discuss your options with your rheumatologist and OB.
If you have tried multiple DMARD alternatives and had inadequate response, your rheumatologist may escalate to biologic or JAK inhibitor therapies. For cancer patients where methotrexate is part of an established protocol, your oncology team will work with the hospital pharmacy and potentially modify chemotherapy regimens per current shortage management guidelines.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Methotrexate also looked for:
More about Methotrexate
34,954 have already found their meds with Medfinder.
Start your search today.





